Gen-Sheng Feng is Professor of Pathology and Molecular Biology at the University of California, San Diego. His research program aims at understanding cross-talks and regulation of signaling pathways in different cell types in health and disease, which was initiated by his discovery of an SH2-containing tyrosine phosphatase Shp2 (originally called Syp) in his postdoc studies with the late Tony Pawson. In the past three decades, his lab is in the driver's position to decipher how Shp2 promotes signaling through the RTK-Ras-Erk pathway.

Catherine Lucey is a White House Correspondent for Bloomberg News.<br>Based in Washington, she has covered the White House and national politics for nearly 20 years. Her reporting has taken her across the country and around the world, with stops in Europe, Asia and South America during President Donald Trump's first term and to the Middle East, India and Ireland with President Joe Biden.<br>Prior to joining Bloomberg, Lucey worked for the Wall Street Journal and the Associated Press.

I am a hepatologist and clinician scientist at Baylor College of Medicine. My clinical research focuses on the intersection on alcohol-related liver injury and metabolic dysfunction and the impact on liver outcomes including liver cancer.

Dr. Christine Hsu is a transplant hepatologist, assistant research physician and staff clinician at National Institute of Diabetes and Digestive and Kidney Diseases at National Institute of Health. She also has a adjunct faculty position at Georgetown University. Her research interests are aimed at improving outcomes of alcohol associated liver disease and hepatocellular carcinoma. She was one of the original principal investigators on ACCELERATE-AH, which is a multi-centered consortium to evaluate outcomes of early liver transplant in patients with alcohol-associated liver disease.

Samantha Kimbrough, MSN, APRN, AGNP-C, is a board-certified nurse practitioner specializing in liver transplant medicine at UT Southwestern Medical Center. Mrs. Kimbrough earned her Bachelor of Science in Nursing from Bellarmine University in Louisville, Kentucky and her Master of Science in Nursing from the University of Cincinnati in Cincinnati, Ohio. She began her nursing career in 2011 as a surgical/trauma ICU nurse at the University of Louisville Hospital in Louisville, Kentucky. In 2017, Mrs.

Hazel Domingo is a physician assistant with ten years of experience in solid organ transplant and hepatology. She trained at Northwestern University and practices at at Northwestern Medicine. She currently serves as the Education Lead for the AASLD Hepatology Associates Special Interest Group. She is also the co-chair and Education and Research Committee lead for the American Society of Transplantation (AST) Advanced Practice Provider Community of Practice.

Dr. He is an Associate Professor in the Department of Medicine at Emory University. His research focuses on identifying novel regulators of systemic and cellular iron homeostasis and elucidating how disrupted iron metabolism contributes to the progression of liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), and diabetes-associated liver injury. Dr.

Andreas Kremer is Head of Hepatology and Vice Director of the Department of Gastroenterology and Hepatology, University Hospital Zurich in Zurich, Switzerland. Professor Kremer is internationally recognized as a clinician, educator and researcher in liver diseases. His translational, clinical and experimental research is focused on molecular mechanisms of immune-mediated and cholestatic liver disease including symptom burden such as fatigue and pruritus, fibrogenesis and development of hepatocellular carcinoma. Prof.

Francis Collins is a physician-scientist. Under his direction, the Human Genome Project produced the first finished sequence of the human DNA instruction book in 2003. From 2009 to 2021, Collins served under three Presidents as the Director of the U.S. National Institutes of Health, the largest supporter of biomedical research in the world. In 2022, he served as Acting Science Advisor to the President, and initiated the planning of a program to eliminate Hepatitis C in the United States.

Dr. David Goldberg is an Associate Professor of Medicine in the Division of Digestive Health and Liver Diseases and Associate Professor of Public Health Sciences at the University of Miami Miller School of Medicine. Dr. Goldberg received his medical degree from the Mount Sinai School of Medicine, followed by residency in internal medicine at New York Presbyterian Hospital-Columbia University Medisal Center.